CD20/BCMA-directed CAR-T cells: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 1 1

Condition	Trials
Immune-mediated Necrotizing Myopathy (IMNM)	1
Lupus	1
Multiple Sclerosis (MS)	1
Multiple sclerosis	1
Myasthenia Gravis	1
Neuromyelitis Optica Spectrum Disorders (NMOSD)	1
Systemic Lupus Erythematosus (SLE)	1
Systemic Sclerosis (SSc)	1

A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
NCT06249438 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location

1 recruiting trial across 8 conditions.

No. For the full record, search ClinicalTrials.gov.